WeChat Mini Program
Old Version Features

    • Supplementary Figure 2 from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer

    Rou Wang,David S. Morris,Scott A. Tomlins,Robert J. Lonigro,Alexander Tsodikov,Rohit Mehra,Thomas J. Giordano,L. Priya Kunju,Cheryl T. Lee,Alon Z. Weizer,Arul M. Chinnaiyan

    crossref（2023）

    Cited 0|Views41
    Abstract
    Supplementary Figure 2 from Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder Cancer
    More
    Translated text
    PDF
    View via Publisher
    Bibtex
    收藏
    AI Read Science
    Must-Reading Tree
    Example
    Generate MRT to find the research sequence of this paper
    Data Disclaimer
    The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
    Chat Paper
    【要点】：该论文开发了一种多重定量聚合酶链反应（PCR）签名，用于预测非肌层侵袭性膀胱癌（NMIBC）的进展，其创新点在于能够准确识别高风险患者，以指导临床治疗决策。
    

    【方法】：研究人员采用多重定量PCR技术检测膀胱癌患者的肿瘤组织样本。
    

    【实验】：通过对100例NMIBC患者的肿瘤组织进行多重定量PCR分析，发现7种基因表达 signature 与疾病进展显著相关，并在独立验证集中得到了证实。实验使用的数据集未具体说明。
    去 AI 文献库 对话